For years, I watched biotech clients get the short end: teams lacked deep industry knowledge, creative frameworks didn't fit, and agency rates delivered junior-level thinking.
When I looked at the investor side — the VC and PE firms backing these companies — I saw the same pattern from the outside in. Brilliant portfolio companies had mediocre brands. Operating teams had value creation plans that addressed everything except the one thing every stakeholder sees first.
Vicar & Lay brings together a principal-led approach with a network of senior life-sciences specialists—strategists, designers, medical illustrators, and verbal identity experts—assembled for each engagement's specific needs. We speak your language, anticipate challenges unique to biotech, and deliver brands built for complex science and investor and stakeholder scrutiny. The result is the strategic rigor of a consultancy, the creative caliber of a top-tier studio, and the specialized fluency that only comes from working in one industry, every single day.
Nobody had built a branding firm specifically for this intersection.
So I did.